Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2023-03-01 Investor Presentation
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Investor Webinar 2 pages 496.4KB
Investor Presentation Classification · 90% confidence The document is an ASX announcement dated 2 March 2023 from Singular Health Group Ltd. It invites shareholders and investors to attend an upcoming investor webinar on 6 March 2023, where the Managing Director and CEO will provide a company update and conduct a Q&A session. The document contains no financial statements, no detailed financial data, no regulatory certifications, or voting results. It is essentially an announcement of an event (investor webinar) rather than a report or transcript of the event. The document length is 3283 characters, which is relatively short and consistent with an announcement. Therefore, this document is best classified as an Investor Presentation (IP) announcement, as it relates to a presentation for investors focusing on company updates and strategy, even though the actual presentation is to be delivered later via webinar.
2023-03-01 English
Resignation of Executive Director 1 page 468.6KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 27 February 2023 regarding the resignation of an Executive Director, Dr Kwang Guan Tay, from Singular Health Group Ltd. It details the director's resignation and ongoing consulting role, includes quotes from the Chairman, and contact information for further inquiries. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. The content clearly relates to a change in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification with high confidence.
2023-02-26 English
Half Year Accounts 27 pages 1.2MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4D for the Half-Year Ended 31 December 2022' and includes detailed financial data for the half-year period ending December 31, 2022, including revenue, net loss, net tangible assets per share, and dividends information. It references an attached 'Interim Financial Report' for the half-year ended 31 December 2022, which contains comprehensive financial statements such as the Consolidated Statement of Profit or Loss, Financial Position, Cash Flows, and Notes. The document also includes a Directors' Report and an Independent Auditor's Review Report. The presence of detailed financial statements and analysis for a period shorter than a full fiscal year, along with the explicit mention of the half-year period, indicates this is an Interim / Quarterly Report. The document is substantive and not merely an announcement or certification, so it is not classified as RPA or RNS. Therefore, the correct classification is 'IR' (Interim / Quarterly Report). H1 2023
2023-02-23 English
Application for quotation of securities - SHG 7 pages 28.2KB
Capital/Financing Update Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the number and type of securities to be quoted, including restricted securities where the escrow period has expired. It includes information about issued capital following quotation and references to IPO and prospectus details. There is no financial report, earnings data, management discussion, or regulatory certification. The document is an announcement related to capital structure changes, specifically the quotation of securities. This fits the definition of a Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive details about securities quotation, not just a brief announcement or report publication notice.
2023-02-13 English
Notification of cessation of securities - SHG 5 pages 25.4KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of cessation of +securities' and details the lapse of certain options (securities) for Singular Health Group Ltd. It provides specific information about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. There is no financial performance data, no management discussion, no earnings information, or any other report content. The document is an announcement about changes in the company's securities, specifically the cessation of certain securities. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as cessation or lapse of securities.
2023-02-13 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 863.2KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement titled 'ACTIVITIES REPORT FOR THE QUARTER – 31st DECEMBER 2022' dated 27th January 2023. It provides a detailed update on the company's operations, financial position, corporate activities, and compliance for the quarter ending December 31, 2022. It includes financial expenditure details, operational highlights, acquisition updates, and regulatory compliance information. The document is comprehensive and contains substantive financial data and analysis for a period shorter than a full fiscal year (a quarter). It is not merely an announcement of a report but the report itself. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q2 2023
2023-01-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.